CEDAR KNOLLS, N.J.,
July 8, 2019 /PRNewswire/
-- MYOS RENS Technology Inc. ("MYOS" or "the Company")
(NASDAQ: MYOS), an advanced nutrition company and the owner of
Fortetropin®, a proprietary bioactive composition
derived from fertilized egg yolk that helps build lean muscle,
enthusiastically congratulates the U.S. Women's World Cup team,
along with their co-Captain and member of Team Yolked®,
Carli Lloyd, for their spectacular
victory in France this past
Sunday.
Ms. Lloyd is a two-time Olympic gold medalist, two-time FIFA
Women's Player of the Year, three-time Olympian, and now a two-time
FIFA Women's World Cup champion in her 4th appearance as a member
of the team.
Joseph Mannello, CEO of MYOS,
commented, "Carli and Team USA had
one the most thrilling World Cup tournaments that I have ever seen.
Her career accomplishments continue to amaze soccer fans around the
world and she will likely go down as one of the greatest
competitors in the history of the sport.
"Carli possesses an unrelenting drive toward excellence coupled
with humility and professionalism. This resonates deeply with
the standards we strive for here at MYOS making Carli an excellent
ambassador of the Yolked brand; we are pleased to be partnered with
her."
About Carli Lloyd
Carli Anne Lloyd is an American
soccer player, two-time Olympic gold medalist, FIFA Women's World
Cup champion, 2015 FIFA Player of the Year and 2016 FIFA Player of
the Year. She currently plays for Sky Blue FC in the NWSL and the
United States Women's National Soccer Team. Lloyd became the first
person ever to score three goals in a FIFA Women's World Cup final,
and the second soccer player in history to score a hat trick in any
senior FIFA World Cup Final. She also scored the gold medal-winning
goals in the finals of the 2008 Summer Olympics and the 2012 Summer
Olympics.
About Yolked®
Yolked® is an NSF Certified for
Sport® all-natural sports nutrition product designed
to work in conjunction with your protein of choice to help your
body utilize that protein more efficiently. Its key ingredient,
Fortetropin®, is made through a patented process that
maintains the vital nutrients of fertilized egg yolks to help build
more lean muscle and decrease muscle loss. For more
information, please visit www.yolked.com.
About MYOS RENS Technology Inc.
MYOS RENS Technology Inc. (MYOS), "The Muscle
Company®", is a Cedar Knolls,
NJ-based advanced nutrition company that develops and
markets products that improve muscle health and performance. MYOS
is the owner of Fortetropin®, a fertilized egg
yolk-based product manufactured via a proprietary process to retain
and optimize its biological activity. Fortetropin has been
clinically shown to increase muscle size and lean body mass in
conjunction with resistance training. MYOS believes Fortetropin has
the potential to redefine existing standards of physical health and
wellness. For more information, please visit www.MYOSRENS.com.
Forward-Looking Statements
Any statements in this release that are not historical facts
are forward-looking statements. Actual results may differ
materially from those projected or implied in any forward-looking
statements. Such statements involve risks and uncertainties,
including but not limited to those relating to product and customer
demand, market acceptance of our products, the ability to create
new products through research and development, the successful
results of strategic initiatives, the success of our products,
including Qurr®, Yolked®, MYOS
Enteral Nutrition Formula™ and MYOS Canine
Muscle Formula® , the success of our research
and development, the results of the clinical evaluation
of Fortetropin® and its effects, the
ability to enter into new partnership opportunities and the success
of our existing partnerships, the ability to generate revenue and
cash flow from sales of our products, the ability to increase our
revenue and gross profit margins, the ability to achieve a
sustainable, profitable business, the effect of economic
conditions, the ability to protect our intellectual property
rights, competition from other providers and products, the
continued listing of our securities on the Nasdaq Stock Market,
risks in product development, our ability to raise capital to fund
continuing operations, and other factors discussed from time to
time in our filings with the Securities and Exchange
Commission. We undertake no obligation to update or revise any
forward-looking statement for events or circumstances after the
date on which such statement is made except as required by
law.
These statements have not been evaluated by the Food and Drug
Administration. Our products are not intended to diagnose, treat,
cure or prevent any disease.
Investor
Relations:
Porter LeVay & Rose
Matthew Abenante, IRC,
SVP
Phone: 212-564-4700
Email:
MYOS@plrinvest.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/myos-rens-technology-congratulates-the-united-states-womens-national-soccer-team-and-team-yolked-member-carli-lloyd-on-winning-the-2019-fifa-womens-world-cup-300880991.html
SOURCE MYOS RENS Technology Inc.